Welcome to the next edition of our “GENEGUT: Behind the Scenes” series — where we spotlight the passionate teams driving innovation across the GENEGUT project. Today, we introduce CarboHyde, based in Budapest, Hungary.
Who They Are
CarboHyde specialises in carbohydrate-based innovation, focusing on cyclodextrins, drug delivery, and specialty chemicals. We stand out through cutting-edge research, tailored solutions, and strong industry collaborations. Our expertise in scale-up, regulatory compliance, and unique formulations enables us to deliver high-value, customised products for pharmaceutical applications.
What They Do in GENEGUT
CarboHyde contributes to the GENEGUT consortium by focusing on the chemistry of biomaterials and the formulation and characterisation of cyclodextrins-based nanoparticles (NPs).
Why GENEGUT Matters
“Working alongside outstanding scientists on a cutting-edge project, we are aiming to develop a first-in-class solution from multiple perspectives to treat Crohn’s disease.”
The Future Impact of GENEGUT
“We hope GENEGUT will pave the way for new pharmaceutical solutions that can significantly improve patients’ lives, not just those living with Crohn’s disease.”
Key Insights and Learnings
“We gained knowledge in the chemistry of synthesising cationic and amphiphilic cyclodextrins, including excipient design, synthesis, and compound characterisation.”
Publications
A review on the application of cyclodextrins as API versus excipient in the treatment of IBD.
What Sets GENEGUT Apart
“This project stands out due to its cutting-edge research, close collaboration with the coordinator and other research groups, and the ambitious goals it strives to achieve.”
Three Words That Describe GENEGUT
“Interesting, collaborative, training”
Fun Fact
“We hire new talents by their first name; 33% of the team members are called Tamás at CarboHyde.”
UK participants in Horizon Europe Project GENEGUT are supported by UKRI grant number 10042451 (Bangor University).